SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-05-008051
Filing Date
2005-06-30
Accepted
2005-06-30 16:27:33
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F y10288e20vf.htm 20-F 1215014
2 EX-1.2: ARTICLES OF ASSOCIATION y10288exv1w2.htm EX-1.2 186929
3 EX-12.1: CERTIFICATION OF THE SENIOR VICE PRESIDENT & GENERAL MANAGER y10288exv12w1.htm EX-12.1 4688
4 EX-12.2: CERTIFICATION OF THE CHIEF FINANCIAL OFFICER y10288exv12w2.htm EX-12.2 4623
5 EX-13: CERTIFICATION OF SENIOR VICE PRESIDENT & GENERAL MANAGER AND CHIEF FINANC y10288exv13.htm EX-13 3906
6 EX-15.A.1: CONSENT OF KOST, FORER ET AL y10288exv15waw1.htm EX-15.A.1 2341
7 GRAPHIC y10288y1028800.gif GRAPHIC 1226
  Complete submission text file 0000950123-05-008051.txt   1420774
Mailing Address FIVE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22286 | Film No.: 05928818
SIC: 2834 Pharmaceutical Preparations